E‑News Updates
-
July 2, 2020Tags: Cynthia Fisher, drug list price rule, drug pricing, Drug Research Initiative, excess CARES funds, HHS, Hospital Price Transparency Rule, Nakela Cook, PCORI, Remdesivir, Shelby Kerns
-
June 24, 2020Tags: CMS proposal, drug list price rule, drug pricing, Mark Warner, Medicare Part D, MedPAC, Patricia Millet, Sarah Lloyd Stevenson, Seema Verma, telehealth
-
June 19, 2020Tags: ACA vote, COVID-19 testing costs, Dr. Anthony Fauci, Pharmaceutical companies lawsuit, PPE Supply, Senators Probe, Steny Hoyer
-
June 10, 2020Tags: FDA extend policies, NAIC, Public Health Option, RAND, Stephen Hahn, telehealth
-
June 3, 2020Tags: ACA expansion, Alex Azar, HHS funding, Joe Biden, Nancy Pelosi, stimulus bill expansions, surprise billing
Roundtable Activity
-
August 6, 2019Tags: congress, drug pricingGiven the amount of recent legislative and regulatory activity regarding a variety of issues relative to drug pricing, the Roundtable presented a webinar for members and friends on Tuesday, August 6th. The upcoming Congressional summer recess provides an opportunity for us to step back and review recent legislative and regulatory activity regarding critical Roundtable priorities. […]
-
July 19, 2019Tags: Andrew MacPherson, Cadillac Tax, Chuck Schumer, Mitch McConnell, repealOn behalf of millions of public sector workers and their families, the Public Sector HealthCare Roundtable has addressed a letter to Senate Majority Leader Mitch McConnell (R-KY) and Senate Minority Democratic Leader Charles Schumer (D-NY) urging the U. S. Senate to provide relief from the 40 percent excise tax on health benefits, known as the […]
Activity Archive